Clinical Trials
5 trialsNCT01472731 2024-05-06
Safety and Imaging Study of GC1008 in Glioma
University Medical Center Groningen
Phase 2 Completed
NCT02581787 2024-03-27
SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer
Stanford University
Phase 1/2 Completed
NCT01112293 2020-04-10
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01401062 2019-03-05
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Completed
NCT01291784 2014-12-08
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1 Terminated